RU2009149637A - Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни - Google Patents
Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни Download PDFInfo
- Publication number
- RU2009149637A RU2009149637A RU2009149637/15A RU2009149637A RU2009149637A RU 2009149637 A RU2009149637 A RU 2009149637A RU 2009149637/15 A RU2009149637/15 A RU 2009149637/15A RU 2009149637 A RU2009149637 A RU 2009149637A RU 2009149637 A RU2009149637 A RU 2009149637A
- Authority
- RU
- Russia
- Prior art keywords
- proton pump
- pump inhibitor
- compound
- subject
- dose
- Prior art date
Links
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title claims abstract 7
- 239000000203 mixture Substances 0.000 title claims 5
- 238000000034 method Methods 0.000 claims abstract 52
- 229940126409 proton pump inhibitor Drugs 0.000 claims abstract 19
- 239000000612 proton pump inhibitor Substances 0.000 claims abstract 19
- 150000001875 compounds Chemical class 0.000 claims abstract 17
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 claims abstract 8
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 claims abstract 8
- 229960004770 esomeprazole Drugs 0.000 claims abstract 8
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical group C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 claims abstract 8
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 claims abstract 8
- 229960000381 omeprazole Drugs 0.000 claims abstract 8
- 229960005019 pantoprazole Drugs 0.000 claims abstract 8
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 claims abstract 8
- 229960004157 rabeprazole Drugs 0.000 claims abstract 8
- 235000012054 meals Nutrition 0.000 claims abstract 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052799 carbon Inorganic materials 0.000 claims abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- XGVADZZDFADEOO-YDALLXLXSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-oxo-4h-thieno[3,2-b]pyridine-6-carboxamide;hydron;chloride Chemical compound Cl.N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=O)=CNC2=C1SC=C2 XGVADZZDFADEOO-YDALLXLXSA-N 0.000 claims 6
- 241000282412 Homo Species 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 1
- AFUWQWYPPZFWCO-LBPRGKRZSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-oxo-4h-thieno[3,2-b]pyridine-6-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=O)=CNC2=C1SC=C2 AFUWQWYPPZFWCO-LBPRGKRZSA-N 0.000 claims 1
- 230000000422 nocturnal effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93353507P | 2007-06-07 | 2007-06-07 | |
| US60/933,535 | 2007-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009149637A true RU2009149637A (ru) | 2011-07-20 |
Family
ID=39619385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009149637/15A RU2009149637A (ru) | 2007-06-07 | 2008-06-04 | Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20090131471A1 (enExample) |
| EP (1) | EP2152263A1 (enExample) |
| JP (1) | JP2010529125A (enExample) |
| CN (1) | CN101868236A (enExample) |
| AU (1) | AU2008262438A1 (enExample) |
| CA (1) | CA2690581A1 (enExample) |
| RU (1) | RU2009149637A (enExample) |
| WO (1) | WO2008153884A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5692838B2 (ja) * | 2009-12-15 | 2015-04-01 | 公立大学法人横浜市立大学 | 感覚器障害モデル動物 |
| US20120225922A1 (en) * | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
| US20150164047A1 (en) * | 2013-11-07 | 2015-06-18 | Urban Pet Haus, LLC | Edible cat toy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔３，２−ｂ〕ピリジン誘導体 |
| US6132768A (en) * | 1995-07-05 | 2000-10-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
| JP3927738B2 (ja) * | 1999-10-25 | 2007-06-13 | キヤノン株式会社 | 通信システム |
| TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| CA2537182A1 (en) * | 2003-08-29 | 2005-03-10 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastrointestinal motility disorders |
-
2008
- 2008-06-04 AU AU2008262438A patent/AU2008262438A1/en not_active Abandoned
- 2008-06-04 US US12/156,787 patent/US20090131471A1/en not_active Abandoned
- 2008-06-04 RU RU2009149637/15A patent/RU2009149637A/ru not_active Application Discontinuation
- 2008-06-04 CA CA2690581A patent/CA2690581A1/en not_active Abandoned
- 2008-06-04 EP EP08768123A patent/EP2152263A1/en not_active Withdrawn
- 2008-06-04 WO PCT/US2008/007038 patent/WO2008153884A1/en not_active Ceased
- 2008-06-04 JP JP2010511187A patent/JP2010529125A/ja active Pending
- 2008-06-04 CN CN200880101836A patent/CN101868236A/zh active Pending
-
2010
- 2010-04-01 US US12/752,702 patent/US20100247584A1/en not_active Abandoned
-
2011
- 2011-07-19 US US13/185,796 patent/US20110275667A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008153884A1 (en) | 2008-12-18 |
| JP2010529125A (ja) | 2010-08-26 |
| US20090131471A1 (en) | 2009-05-21 |
| WO2008153884A8 (en) | 2009-03-26 |
| AU2008262438A1 (en) | 2008-12-18 |
| CA2690581A1 (en) | 2008-12-18 |
| US20100247584A1 (en) | 2010-09-30 |
| CN101868236A (zh) | 2010-10-20 |
| EP2152263A1 (en) | 2010-02-17 |
| US20110275667A1 (en) | 2011-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003114752A (ru) | Лечение желудочно-кишечных стромальных опухолей | |
| CN104023715B (zh) | 激酶抑制剂的副作用降低剂 | |
| MXPA05007857A (es) | Moduladores derivados de indol de receptores nucleares de hormonas esteroideas. | |
| JP6792269B2 (ja) | 夜間胃酸過分泌に対するベンズイミダゾール誘導体の使用 | |
| JP2003500442A5 (enExample) | ||
| JP2008515905A5 (enExample) | ||
| RU2012118974A (ru) | Комбинации ингибитора pi3k и ингибитора мек | |
| TW201136916A (en) | New uses | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2009532438A5 (enExample) | ||
| RU2014129508A (ru) | Новая комбинация | |
| JP2009517411A5 (enExample) | ||
| RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| EA200601286A1 (ru) | Фармацевтические композиции, содержащие ингибитор протонового насоса и прокинетический агент | |
| CA2504665A1 (en) | Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia | |
| EA200800075A1 (ru) | Схема дозирования для празугреля | |
| JP2010529125A5 (enExample) | ||
| RU2004126447A (ru) | Лечение ревматоидного артрита | |
| KR20060130619A (ko) | 유기 화합물의 조합물 | |
| WO2008153884A8 (en) | Compositions useful for treating gastroesophageal reflux disease | |
| CN117425477A (zh) | 包含1-(3-氰基-1-异丙基-吲哚-5-基)吡唑-4-甲酸的药物组合物 | |
| RU2007129408A (ru) | Способ выращивания поросят в период откорма | |
| RU2014128528A (ru) | Лечение диабета I и II типа | |
| CA2526594A1 (en) | Use of tyrosine kinase inhibitors to treat diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20130118 |